Global Animal Anti Rabies Vaccine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Animal Anti Rabies Vaccine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Rabies is a zoonotic disease (a disease transmitted from animals to humans) caused by the rabies virus. Rabies is a virus that is usually transmitted by animal bites or scratches.Animal anti rabies vaccine is an effective prophylactic injection
Animal Anti Rabies Vaccine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Animal Anti Rabies Vaccine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Pre-exposure Prophylaxis and Post-exposure Prophylaxis are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Animal Anti Rabies Vaccine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Animal Anti Rabies Vaccine key manufacturers include Sanofi, GSK, Merck, Yisheng Group, Serum Institute of India, Cadila Pharmaceuticals, Boehringer Ingelheim and Liaoning Chengda, etc. Sanofi, GSK, Merck are top 3 players and held % sales share in total in 2022.
Animal Anti Rabies Vaccine can be divided into Vero Cell Rabies Vaccine, Baby Hamster Kidney (BHK) Rabies Vaccine, Chick Embryo Cell Rabies Vaccine and Other, etc. Vero Cell Rabies Vaccine is the mainstream product in the market, accounting for % sales share globally in 2022.
Animal Anti Rabies Vaccine is widely used in various fields, such as Pre-exposure Prophylaxis and Post-exposure Prophylaxis, etc. Pre-exposure Prophylaxis provides greatest supports to the Animal Anti Rabies Vaccine industry development. In 2022, global % sales of Animal Anti Rabies Vaccine went into Pre-exposure Prophylaxis filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Animal Anti Rabies Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Sanofi
GSK
Merck
Yisheng Group
Serum Institute of India
Cadila Pharmaceuticals
Boehringer Ingelheim
Liaoning Chengda
Segment by Type
Vero Cell Rabies Vaccine
Baby Hamster Kidney (BHK) Rabies Vaccine
Chick Embryo Cell Rabies Vaccine
Other
Pre-exposure Prophylaxis
Post-exposure Prophylaxis
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Animal Anti Rabies Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Animal Anti Rabies Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Animal Anti Rabies Vaccine industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Animal Anti Rabies Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Animal Anti Rabies Vaccine introduction, etc. Animal Anti Rabies Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Animal Anti Rabies Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Animal Anti Rabies Vaccine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Animal Anti Rabies Vaccine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Pre-exposure Prophylaxis and Post-exposure Prophylaxis are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Animal Anti Rabies Vaccine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Animal Anti Rabies Vaccine key manufacturers include Sanofi, GSK, Merck, Yisheng Group, Serum Institute of India, Cadila Pharmaceuticals, Boehringer Ingelheim and Liaoning Chengda, etc. Sanofi, GSK, Merck are top 3 players and held % sales share in total in 2022.
Animal Anti Rabies Vaccine can be divided into Vero Cell Rabies Vaccine, Baby Hamster Kidney (BHK) Rabies Vaccine, Chick Embryo Cell Rabies Vaccine and Other, etc. Vero Cell Rabies Vaccine is the mainstream product in the market, accounting for % sales share globally in 2022.
Animal Anti Rabies Vaccine is widely used in various fields, such as Pre-exposure Prophylaxis and Post-exposure Prophylaxis, etc. Pre-exposure Prophylaxis provides greatest supports to the Animal Anti Rabies Vaccine industry development. In 2022, global % sales of Animal Anti Rabies Vaccine went into Pre-exposure Prophylaxis filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Animal Anti Rabies Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Sanofi
GSK
Merck
Yisheng Group
Serum Institute of India
Cadila Pharmaceuticals
Boehringer Ingelheim
Liaoning Chengda
Segment by Type
Vero Cell Rabies Vaccine
Baby Hamster Kidney (BHK) Rabies Vaccine
Chick Embryo Cell Rabies Vaccine
Other
Segment by Application
Pre-exposure Prophylaxis
Post-exposure Prophylaxis
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Animal Anti Rabies Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Animal Anti Rabies Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Animal Anti Rabies Vaccine industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Animal Anti Rabies Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Animal Anti Rabies Vaccine introduction, etc. Animal Anti Rabies Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Animal Anti Rabies Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.